Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...
With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...
Here are five medical breakthroughs that gave us hope in 2025. In February, a baby with a rare, often fatal genetic disorder ...
The Federal Government has trained scientists drawn from key research institutions across the country on mRNA technology ...
From smartphones to artificial intelligence, technology moved from the margins of daily life to its center, transforming how ...
A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...
Morning Overview on MSN
MIT team finds a way to reboot the immune system
Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns ...
Throughout 2025, CancerVax achieved substantial scientific progress, expanded its leadership and intellectual property portfolio, and advanced the development of its AI-engineered "Smart mRNA" and ...
The same politicians who swore that inflation was “transitory” during the last presidential administration have suddenly found religion on the issue of “affordability.” ...
Book review by Dr Anne Sarzin According to the authors of Abundance: How we build a better future, their book is dedicated to ...
The era of CureVac as an independent, publicly traded company has drawn to a close. BioNTech SE has successfully completed ...
The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback